On January 25, 2018, as part of the ongoing restructuring of the Cytori Therapeutics, Inc., David M. Rickey and Gail K. Naughton, Ph.D. submitted their resignations as members of the Board of Directors of the company, effective immediately, and the Board of Directors decreased its size from seven to five members. In addition, Richard J. Hawkins was appointed to serve as Chairman to succeed Mr. Rickey. Mr. Rickey’s and Ms. Naughton’s decisions to resign did not result from any disagreement with the Company concerning any matter relating to the Company’s operations, policies or practices.